The SENTINEL Project
SENTINEL Plus is based on the SENTINEL project, an on-going quality improvement initiative undertaken in Hull and East Yorkshire, supported through a Joint Working Agreement between Hull University Teaching Hospitals NHS Trust and AstraZeneca UK.
The SENTINEL project developed an intervention to implement the local asthma guideline which has a focus on reducing short-acting beta agonist (SABA) over-reliance and using Maintenance and Reliever Therapy (MART) for appropriate patients.
The intervention was designed in collaboration with asthma clinicians and patients using experience based co-design methodology, and includes the 5 core elements detailed on the right to support sustained improvements in asthma care.
Pilot data from the SENTINEL project has demonstrated that implementation of a MART focussed asthma guideline can substantially reduce SABA prescribing and reduce the proportion of all inhaled therapies that are a SABA. This data was presented at the European Respiratory Society Conference 2021. 1,2
A detailed evaluation is on-going as the intervention continues to expand to additional primary care networks (PCNs) within Hull and East Yorkshire as part of the SENTINEL project.
- Crooks, M et al. Impact of maintenance and reliever therapy (MART) focussed asthma guideline on SABA prescriptions. Abstract presented at European Respiratory Society (ERS) International Congress, 2021; Sep 5-8: Abstract no. OA80
- Open Prescribing. Available from https://openprescribing.net/pcn/U64827/measures/?tags=respiratory (Accessed 5th October 2021)